Catalyst Wire Dossier Catalyst Wire Dossier

NUBEQA (darolutamide)

darolutamide · Bayer
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for NUBEQA (darolutamide), covering 2018-07-30 to 2026-02-17. Get the full timeline:

Most recent: Clinical Trial Update: How Darolutamide Plus Hormone Therapy Works for Men With Advanced Prostate Cancer in Everyday Medical Practice in Germany

See pricing